| Time | Program |
|---|---|
| 12:00–12:30 | Arrival, food, coffee, mingling (coffee, snacks) |
| 12:30–12:40 | Lars Christian Stene: Welcome and short introduction |
| 12:40–12:55 | Per Magnus: Kjersti’s role in setting up the NIPH biobank and starting MIDIA |
| 12:55–13:00 | Liv Patitel: The first employee in the biobank with Kjersti |
| 13:00–13:15 | Turid Wetlesen: Starting MIDIA with Kjersti (in Norwegian) |
| 13:15–13:35 | German Tapia: Fecal virus infection and islet autoimmunity in MIDIA |
| 13:35–14:00 | Break with fruit, drinks, coffee |
| 14:00–14:30 | Ondrej Cinek: With MIDIA since May 1998: from the start of Kjersti’s lab at Folkehelse to faecal viromics today |
| 14:30–15:15 | Zdeněk Šumník: Teplizumab in Focus – Expectations and Practical Insights |
| 15:15–15:30 | Lars Christian Stene: Summary, the way forward, and end of seminar |
Om Kjersti Skjold Rønningen (In Norwegian)
Kjersti planla, designet og ledet MIDIA-studien som startet rekruttering i 2001. Hun gikk uventet bort fredag 21. mars 2025. Kjersti var lege og ekspert på HLA-geners rolle ved utviklingen av type 1 diabetes. Etter forskningsopphold i Edmonton, Canada, jobbet hun ved FHI fra 1998. Hun ledet oppbyggingen av biobanken til Den norske mor, far og barn-undersøkelsen (MoBa). Kjersti hadde som mål å finne miljøårsakene til type 1-diabetes for å gjøre det mulig å forebygge sykdommen.
About the speakers
Lars Christian Stene: Senior Researcher at NIPH and currently PI of the MIDIA study
Per Magnus: The first PI of the MoBa study, epidemiologist and medical geneticist
Liv Patitel: The first employee at the NIPH Biobank, currently Quality Coordinator at OUS Biobank
Turid Wetlesen: Retired Public Health Nurse, head of MIDIA recruitment and participant contact from 2001
German Tapia: Senior Researcher at NIPH, did his PhD and postdoc with MIDIA
Ondřej Cinek, MD, PhD: Professor of Medical Biology at Charles University Prague, expert in pediatric diabetes and microbiology including viromics and metagenomics, collaborator of the MIDIA study since its inception
Zdeněk Šumník, MD, PhD: Professor of Pediatrics at Charles University Prague, Head of Pediatrics at University Hospital Motol, recruited participants to the teplizumab PROTECT study and coauthor of the NEJM 2023 paper